translated from Spanish: In a week I would arrive in Mexico Pfizer vaccine against COVID

The vaccine developed by Pfizer can already be used in Mexico, so the lab would be sending it in about a week. 
“We have been working on the import process. We have a collaboration group in the government, where the Tax Administration System (SAT), the Directorate General of Customs, the Secretariat of Foreign Affairs (SRE), the Senior Treasury Officer and several offices of the Ministry of Health participate, and we are prepared to issue the procurement order. Once this is done, Pfizer for eight days conditions the product and ships it,” he said. 
The undersecretary said distribution points have already been announced: military installations located in CDMX and Coahuila. López-Gatell emphasized that during December no one other than health personnel previously selected by the institutions will be vaccinated. “It’s very little for now, at the start it’s 125 thousand people, but on an ongoing basis, without pause, we will continue during January and February vaccinating this risk group.” 
Read: Why will coVID be vaccinated by age and starting with CDMX and Coahuila?
Coferpris reported in a statement that from 26 November it reviewed, evaluated and issued the documentation submitted to this commission for emergency health authorization of the Pfizer-BioNtech COVID-19 vaccine. 
The Committee on New Molecules sessioned on 11 December 2020. Its 24 members voted and gave a favourable opinion, unanimously, for emergency use. From this, the Cofepris issued the authorization, under that figure. 
The same was done, minutes later, by the U.S. Food and Drug Administration (FDA). A panel of experts advising the FDA on Thursday gave its approval to the Pfizer vaccine for use in people over the age of 16. The agency planned to publish the formal authorization this Saturday, The New York Times reported. But time has accelerated after President Donald Trump criticized not authorizing the vaccine faster. 
Find out: Health adds up to 12 thousand 253 cases of COVID-19, the highest figure reported in a day
This Friday, the FDA authorized Pfizer’s COVID-19 vaccine under the same figure as Mexico did: for emergency use, which paved the way for millions of vulnerable people to start receiving it in that country as well.
With the decision this nation became the sixth in addition to the United Kingdom, Bahrain, Canada, Saudi Arabia and Mexico to approve the vaccine. Other authorisations are expected in a few weeks, including that of the European Union.
What is an authorization for emergency use
According to information published on the FDA website, this figure is a response to a public health emergency statement for which there are no adequate, approved or available alternatives and allows “the use of un approved medical products to diagnose, treat or prevent serious or life-threatening illnesses caused by threatening agents”. 
In a statement ingpointing statements from the agency’s commissioner, Stephen Hahn, the FDA noted that although emergency use authorizations (THEUs) have received increased attention during the COVID-19 pandemic, they are not a new tool.
“In emergency situations where there are no adequate, approved and available alternatives, the FDA has the power to authorize the use of medical products under specific conditions, before all the evidence that would be necessary for full approval is available,” Hahn said. 
Read more:Oxford-AstraZeneca to combine its vaccine with Russian Sputnik V for trials
For a U.S. to be authorized, the commissioner added in the document, “FDA scientists conduct a rigorous evaluation of available tests on a medical product. We work with sponsors to continue collecting and reviewing additional data on product safety and efficacy. If available scientific evidence changes or if new information is available, we may change direction and adapt the authorization, which may include revoking it.”
 At the COVID-19 press conference on Thursday, December 10, undersecretary of health Hugo López Gatell specified that in Mexico, emergency approval is not yet the final health record. 
“Clinical trials are still ongoing, not over, and need to continue until the study of all people is completed. But the scientific evidence with the follow-up so far has been made of patients or recruited persons is enough to demonstrate safety and efficacy.” 
What we do andn Political Animal requires professional journalists, teamwork, dialogue with readers and something very important: independence. You can help us keep going. Be part of the team.
Subscribe to Animal Politics, receive benefits and support free journalism.#YoSoyAnimal

Original source in Spanish